Actinomycin D in the treatment of methotrexate-resistant malignant trophoblastic tumours.
D000328:Adult; D001932:Brain Neoplasms / Q000175:diagnosis; D006063:Chorionic Gonadotropin / Q000652:urine; D003609:Dactinomycin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007044:Hysterectomy; D007680:Kidney Neoplasms / Q000175:diagnosis; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D011247:Pregnancy; D011379:Prognosis; D013997:Time Factors; D014328:Trophoblastic Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery
D006063:Chorionic Gonadotropin; D003609:Dactinomycin; D015122:Mercaptopurine; D008727:Methotrexate